Ahn-Gook Pharmaceutical Co., Ltd. (KOSDAQ: 001540)
South Korea
· Delayed Price · Currency is KRW 7,130.00
-20.00 (-0.28%)
Oct 11, 2024, 9:00 AM KST
Ahn-Gook Pharmaceutical Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Operating Revenue | 252,480 | 233,676 | 205,389 | 163,534 | 143,364 | 155,852 | Upgrade
|
| Other Revenue | - | - | -0 | - | - | - | Upgrade
|
| Revenue | 252,480 | 233,676 | 205,389 | 163,534 | 143,364 | 155,852 | Upgrade
|
| Revenue Growth (YoY) | 12.60% | 13.77% | 25.59% | 14.07% | -8.01% | -16.09% | Upgrade
|
| Cost of Revenue | 100,810 | 93,105 | 79,109 | 62,516 | 58,471 | 62,275 | Upgrade
|
| Gross Profit | 151,669 | 140,571 | 126,279 | 101,018 | 84,893 | 93,576 | Upgrade
|
| Selling, General & Admin | 132,416 | 121,343 | 102,052 | 83,157 | 64,021 | 73,290 | Upgrade
|
| Research & Development | 12,334 | 12,255 | 12,957 | 17,328 | 16,993 | 15,583 | Upgrade
|
| Operating Expenses | 146,271 | 135,509 | 116,899 | 102,102 | 84,942 | 91,159 | Upgrade
|
| Operating Income | 5,399 | 5,061 | 9,381 | -1,084 | -49.1 | 2,418 | Upgrade
|
| Interest Expense | -1,416 | -142.75 | -160.41 | -116.83 | -756.89 | -1,035 | Upgrade
|
| Interest & Investment Income | 486.93 | 388.54 | 407.43 | 335.82 | 971.68 | 755.68 | Upgrade
|
| Earnings From Equity Investments | 1,943 | -1,641 | -1,645 | 2,613 | 1,780 | 1,134 | Upgrade
|
| Currency Exchange Gain (Loss) | 26.82 | -79.74 | -82.27 | 133.07 | -302.34 | 75.58 | Upgrade
|
| Other Non Operating Income (Expenses) | 1,375 | -258.15 | 336.26 | -246.68 | -1,431 | 68.98 | Upgrade
|
| EBT Excluding Unusual Items | 7,814 | 3,328 | 8,237 | 1,634 | 212.8 | 3,417 | Upgrade
|
| Gain (Loss) on Sale of Investments | 422.5 | 921.68 | -889.55 | 2,033 | 625.7 | 290.06 | Upgrade
|
| Gain (Loss) on Sale of Assets | 13,501 | 17.13 | 28.25 | 138.65 | -60.42 | 24.51 | Upgrade
|
| Asset Writedown | - | - | - | - | - | -1,556 | Upgrade
|
| Pretax Income | 21,738 | 4,267 | 7,375 | 3,805 | 778.08 | 2,176 | Upgrade
|
| Income Tax Expense | 6,761 | 3,269 | 496.14 | 61.49 | 2,166 | 33.73 | Upgrade
|
| Earnings From Continuing Operations | 14,977 | 998.28 | 6,879 | 3,744 | -1,388 | 2,142 | Upgrade
|
| Net Income to Company | 14,977 | 998.28 | 6,879 | 3,744 | -1,388 | 2,142 | Upgrade
|
| Minority Interest in Earnings | 372.42 | 291.85 | -3.95 | 195.56 | 72.98 | 393.69 | Upgrade
|
| Net Income | 15,349 | 1,290 | 6,875 | 3,939 | -1,315 | 2,536 | Upgrade
|
| Net Income to Common | 15,349 | 1,290 | 6,875 | 3,939 | -1,315 | 2,536 | Upgrade
|
| Net Income Growth | 96.77% | -81.24% | 74.54% | - | - | -80.82% | Upgrade
|
| Shares Outstanding (Basic) | 11 | 11 | 11 | 11 | 11 | 11 | Upgrade
|
| Shares Outstanding (Diluted) | 11 | 11 | 11 | 11 | 13 | 11 | Upgrade
|
| Shares Change (YoY) | 0.00% | -0.12% | -0.65% | -9.44% | 10.37% | -2.56% | Upgrade
|
| EPS (Basic) | 1350.51 | 113.51 | 604.21 | 343.93 | -114.79 | 221.27 | Upgrade
|
| EPS (Diluted) | 1350.51 | 113.51 | 604.00 | 343.93 | -114.79 | 221.27 | Upgrade
|
| EPS Growth | 96.91% | -81.21% | 75.62% | - | - | -80.52% | Upgrade
|
| Free Cash Flow | -83,829 | -6,802 | -1,143 | -2,563 | -12,929 | 18,340 | Upgrade
|
| Free Cash Flow Per Share | -7375.87 | -598.47 | -100.41 | -223.77 | -1022.23 | 1600.47 | Upgrade
|
| Dividend Per Share | 220.000 | 220.000 | - | - | - | - | Upgrade
|
| Gross Margin | 60.07% | 60.16% | 61.48% | 61.77% | 59.22% | 60.04% | Upgrade
|
| Operating Margin | 2.14% | 2.17% | 4.57% | -0.66% | -0.03% | 1.55% | Upgrade
|
| Profit Margin | 6.08% | 0.55% | 3.35% | 2.41% | -0.92% | 1.63% | Upgrade
|
| Free Cash Flow Margin | -33.20% | -2.91% | -0.56% | -1.57% | -9.02% | 11.77% | Upgrade
|
| EBITDA | 11,011 | 10,084 | 14,311 | 3,423 | 4,634 | 6,272 | Upgrade
|
| EBITDA Margin | 4.36% | 4.32% | 6.97% | 2.09% | 3.23% | 4.02% | Upgrade
|
| D&A For EBITDA | 5,613 | 5,023 | 4,930 | 4,507 | 4,683 | 3,854 | Upgrade
|
| EBIT | 5,399 | 5,061 | 9,381 | -1,084 | -49.1 | 2,418 | Upgrade
|
| EBIT Margin | 2.14% | 2.17% | 4.57% | -0.66% | -0.03% | 1.55% | Upgrade
|
| Effective Tax Rate | 31.10% | 76.61% | 6.73% | 1.62% | 278.43% | 1.55% | Upgrade
|
| Advertising Expenses | - | 5,543 | 5,776 | 5,482 | 3,935 | 8,206 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.